drugset / Trial / NCT02674880

Hyaluronic Acid in Acute Exacerbation of COPD - Duration Of Noninvasive Assistance

NCT02674880

RandomizedParallel-groupSingle-blindTreatment

Summary

The objective of this study is to test the effect of High Molecular Weight Hyaluronic Acid (HMW-HA) on Non Invasive Ventilation (NIV) effectiveness in patients admitted to a sub-intensive care unit for respiratory failure due to acute exacerbation of Chronic Obstructive Pulmonary Disease (COPD).

Timeline

Start
2016-03
Primary completion
2019-01
Completion
2019-09

Drugs

EvaluationDrugModalityDoseRoute
Subject HMW-HA Other / unclassified 0.3 % Other
Subject HMW-HA Other / unclassified 5 ml Other